BAY-2925976

N/A

Report date: 2024/12/18 13:29:37
NME

Base Information

Drug NameBAY-2925976
Drug Alias NameBAY-2925976BAY2925976
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlpha-2c adrenergic receptor antagonists
TargetsAlpha-2c adrenergic receptor
Therapy Area/IndicationsSleep Apnea, Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsSleep Apnea, Obstructive
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A